期刊文献+

双膦酸盐类药物的研究进展与应用评价 被引量:2

Research Progress and Application Evaluation of Diphosphonate Preparations
下载PDF
导出
摘要 目的:为临床合理选用双膦酸盐类药物提供参考。方法:介绍双膦酸盐类药物的研究进展,对其在一些疾病中的应用进行了评 价。结果与结论:双膦酸盐类药物具有抑制骨吸收和防止动脉、肾脏及皮肤钙化等作用,为治疗骨质疏松等病症开辟了新的途径。 OBJECTIVE:To provide rational use of diphosphcmate preparations for reference. METHODS:To give account of research progress of diphosphonate preparations and to evaluate their application in some diseases. RESULTS & CONCLUSION :Diphosphonate preparations can inhibit absorption of bone and prevent calcification of artery, kidney and skin. They open up a new way in treatment of some diseases, such as osteoporosis.
作者 张石革
机构地区 北京积水潭医院
出处 《中国医院用药评价与分析》 2001年第4期212-214,共3页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 双膦酸盐类药物 钙调节剂 骨质疏松 临床应用 变形性骨炎 diphosphonale research progress evaluation of application
  • 相关文献

参考文献21

  • 1RogersMJ. XiongX, Brown ER, et al. Structureactivety relationships of new heterocycle-containing bisphosphanates as inhibitors of bone resorption and as inhibitors of growth of dictyostelium discoideum amoebae[J ]. Mol Pharmacal, 1995, 47(2): 398.
  • 2Van Beek E,Hoekstra M,Vande Ruit M,et al. Structural requirements for bisphosphanates actions in vitro[J ].J Bone Miner Res, 1994, 9:1 875.
  • 3Coukell .AJ, Markham A.Pamidronate a review of its use in the management of osteolytic bone metastases, tomour-induced hypercalcaemia and Paget's disease of bone[J ]. Drugs Aging, 1998, 12:149.
  • 4Rosen C J, Kessenich CR. Comparative clinical pharmacology and therapeutic use of bisphosphanates in metabolic bone disease[J ]. Drugs, 1996, 51(4) :537.
  • 5Jeal W, Barradell LB, Mctavish D.Alendronata: a review of its pharmacological properties and therapetuic efficacy in postmenopausal osteoporosis[J ]. Drugs, 1997, 53(3) :415.
  • 6Boisser S, Magnetto S, Frappart L, et al. Bisphosphanates inhibit prostate and breast carcinoma cell adhesion to unmineralized and mineralized bone extra cellular matrices[J ]. Cancer Res, 1997, 57(18) :3 890.
  • 7Kyle RA.Efficacy of bisphosphanates actions in treatment multiple myeloma[J ]. Ann Intem Med, 2000, 132(9) :734.
  • 8Black DM, Reiss TF, Nevitt MC, et al. Design of the fracture intervention trial[J ] . Osteoporosis Int, 1993, 3 (Suppl 3):29.
  • 9Adimi S, Baroni MC, Broggini M, et al. Treatment of post-menopausal osteoporosis with continuous daily oral alendronate in comparision with either placebo or intranasal salmon calcitonin[J ]. Osteoporosis Int, 1993, 3(Suppl) :21.
  • 10Cosman F, Nieves J,Woelfert L, et al. Alendronate does not block the anabolic effect of PTH in postmenopausal osteoporotic women[J] . J Bone Miner Res, 1998, 13(6):1 051.

二级参考文献1

共引文献21

同被引文献57

  • 1马兴明.老年股骨颈骨折全髋置换术与半髋关节置换术疗效比较[J].中国医学前沿杂志(电子版),2013,5(11):45-47. 被引量:17
  • 2闫丽娅,周波,侯菊倩,王晓红,韩延柏.中国沈阳髋部骨折的流行病学研究[J].中国骨质疏松杂志,1996,2(2):69-71. 被引量:15
  • 3林秀峰,俞惠新,谭成,陈波,王铁生,王博诚.双膦酸盐对肺癌细胞增殖的影响[J].中国肺癌杂志,2005,8(6):510-513. 被引量:4
  • 4Dunford JE, Thompson K, Coxon FP, etal. Structure-Activity relationships for inhibition of famesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogencontaining bisphosphonates[J]. Cellular and molecular, 2001, 296 (2): 235-242.
  • 5Dominique H, Benjamin O, Francois G, et al. Bisphosphohates: new therapeutic agents for the treatment of bone tumors [J]. Trends in Molecular Medicine, 2004, 10 (7) : 337-343.
  • 6Manuela B, Meriem H, Gr gory B, et al. Zoledronate sensitizes endothelial ceils to tumor necrosis factor induced programmed cell death[J]. J Biol Chem, 2003, 278 (44) : 43603- 43614.
  • 7Coxon JP, Oades GM, Kirby RS, et al. Zoledronic acid induces apoptosis and inhibits adhesion to mineralized matrix in prostate cancer cells via inhibition of protein prenylation[J]. BJU Int, 2004, 94 (1): 164-170.
  • 8Green JR. Antitumor effects of bisphosphonates[J]. Cancer, 2003, 97 (3 Suppl): 840-847.
  • 9Sandrine B, Mercedes F, Olivier P, et al. Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases [J]. Cancer Research, 2000, 60: 2949-2954.
  • 10Rogers MJ. New insights into the molecular mechanisms of action of hisphosphonates[J]. Curt Pharm Des, 2003, 9 (32): 2643-2658.

引证文献2

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部